Research
Researchers found that pairing a next-generation immunotherapy with standard hormone therapy before surgery may help overcome a long-standing barrier in early-stage prostate cancer treatment.
Latest stories
International
June 30, 2025
Neurology Patient Stories
June 30, 2025
Featured News
June 27, 2025
Individualized Medicine
June 18, 2025
Sign up to receive email notifications
Explore more topics
Sign up
Mayo Clinic Connect
An online patient support community